Comparison of Safety and Efficacy of TOCOSOL(R) Paclitaxel Versus Taxol(R) for Treatment of Metastatic Breast Cancer

PHASE3TerminatedINTERVENTIONAL
Enrollment

821

Participants

Timeline

Start Date

September 30, 2005

Primary Completion Date

September 30, 2007

Study Completion Date

September 30, 2007

Conditions
Breast Neoplasm
Interventions
DRUG

Taxol

DRUG

TOCOSOL Paclitaxel

100 mg/m2/week

Trial Locations (14)

33901

Florida Cancer Specialists, Fort Myers

37203

The Sarah Cannon Research Institute, Nashville

37404

Chattanooga Oncology & Hematology Associates, PC, Chattanooga

43235

Hematology Oncology Consultants, Inc, Columbus

48076

Southfield Oncology Institute, Inc, Southfield

49085

Oncology Care Associates, Saint Joseph

58501

Mid Dakota Clinic, Bismarck

79410

Joe Arrington Cancer Research and Treatment Center, Lubbock

83712

Mountain State Tumor Institute, Boise

92270

Desert Hematology Oncology Medical Group, Rancho Mirage

94704

Alta Bates Comprehensive Cancer Center, Berkeley

95204

Stockton Hematology Oncology, Stockton

03756

Norris Cotton Cancer Center, Dartmouth Hitchcock Medical Center, Lebanon

07109

Essex Oncology of North Jersey, Belleville

Sponsors
All Listed Sponsors
lead

Achieve Life Sciences

INDUSTRY